Titan Pharmaceuticals, Inc.
TTNP
$4.40
-$0.05-1.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -563.00K | -790.00K | -763.00K | -2.09M | -1.06M |
| Total Depreciation and Amortization | -- | 0.00 | 0.00 | 3.00K | 2.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 0.00 | 0.00 | -1.00K | -1.00K |
| Change in Net Operating Assets | -304.00K | 284.00K | 70.00K | 23.00K | 446.00K |
| Cash from Operations | -867.00K | -506.00K | -693.00K | -2.07M | -613.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -19.00K | -62.00K | -- | -- | -- |
| Cash from Financing | -19.00K | -62.00K | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -886.00K | -568.00K | -693.00K | -2.07M | -613.00K |